Follow the 메디아나 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 메디아나 has recorded 20 public disclosures. The latest transaction was reported on 12 January 2024 (Purchase). Among the most active insiders: 길문종. All data is free.
20
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
3 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Mediana is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of innovative medical equipment.